Home › Non-Small Cell Lung Cancer › Tennessee › Knoxville

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Knoxville, TN

14 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Knoxville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Nagre-recruitPhase 2/3

Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road /ID# 277891, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07155187

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Nagre-recruitPhase 3

Thompson Cancer Survival Center ( Site 0168), Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06623422

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Nagre-recruitPhase 3

The University of Tennessee Medical Center ( Site 3223), Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07513376

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Tennessee Cancer Specialists, Knoxville
Tennessee Cancer Specialists - Parkwest Location, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07144280

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Nagre-recruitPhase 3

University of Tennessee Medical Center Knoxville ( Site 0082), Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Tennessee Cancer Specialists Dowell Springs location, Knoxville
University of Tennessee Medical Center, Knoxville
Tennessee Cancer Specialists - Parkwest Location, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2

Tennessee Cancer Specialists, Knoxville
University of Tennessee, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2

University of Tennessee Medical Center, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07154290

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Nagre-recruitPhase 2

University of Tennessee Medical Center, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07489066

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

University of Tennessee Medical Center, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06890598

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

University of Tennessee Medical Center, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Nagre-recruitPhase 2/3

University of Tennessee Medical Center, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06712316

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3

University of Tennessee Medical Center, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Nagre-recruitPhase 2

University of Tennessee Medical Center, Knoxville

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT04614103

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Knoxville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.